INDRAMEDCO Q1 FY27 results at a glance
INDRAPRASTHA MEDICAL CORP Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹406 cr |
|---|
| Revenue YoY | +11.3% |
|---|
| Operating profit | ₹68.05 cr |
|---|
| Operating margin | 16.8% |
|---|
| Net profit | ₹55.85 cr |
|---|
| Net profit YoY | +8.5% |
|---|
| Net profit QoQ | +33.9% |
|---|
| Net margin | 13.8% |
|---|
| Basic EPS | ₹6.09 |
|---|
| TTM revenue | ₹1,508 cr |
|---|
| TTM net profit | ₹190 cr |
|---|
| TTM net margin | 12.6% |
|---|
INDRAMEDCO Q1 FY27 results: what the numbers say
INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹406 cr and a net profit of ₹55.85 cr, translating into earnings per share of ₹6.09.
Compared with the same quarter a year earlier, revenue grew by +11.3% and net profit grew by +8.5%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹68.05 cr, an operating margin of 16.8% versus 17.2% a year ago — a contraction of 0.5 percentage points.
INDRAMEDCO quarter-wise results table
Net profit
₹55.85 cr
+8.5% YoY
Operating profit
₹68.05 cr
+8.1% YoY
INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹406 cr | ₹68.05 cr | ₹55.85 cr | 16.8% | 13.8% | ₹6.09 | +8.5% | +33.9% |
| Q4 FY262026-03-31 | ₹365 cr | ₹49.17 cr | ₹41.7 cr | 13.5% | 11.4% | ₹4.55 | +1.7% | +1.7% |
| Q3 FY262025-12-31 | ₹372 cr | ₹50.7 cr | ₹41 cr | 13.6% | 11.0% | ₹4.47 | — | -20.3% |
| Q1 FY262025-06-30 | ₹365 cr | ₹62.97 cr | ₹51.46 cr | 17.2% | 14.1% | ₹5.61 | — | +25.5% |
| Q4 FY252025-03-31 | ₹334 cr | ₹50.41 cr | ₹41.01 cr | 15.1% | 12.3% | ₹4.47 | — | — |
| TTM (last 4 quarters) | ₹1,508 cr | ₹231 cr | ₹190 cr | 15.3% | 12.6% | ₹20.72 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
INDRAMEDCO quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
INDRAPRASTHA MEDICAL CORP quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹406 cr | ₹365 cr | ₹372 cr | ₹365 cr | ₹334 cr |
|---|
| Total expenses | ₹338 cr | ₹316 cr | ₹321 cr | ₹302 cr | ₹283 cr |
|---|
| Gross profit | ₹152 cr | ₹130 cr | ₹138 cr | ₹139 cr | ₹121 cr |
|---|
| Operating profit (EBIT) | ₹68.05 cr | ₹49.17 cr | ₹50.7 cr | ₹62.97 cr | ₹50.41 cr |
|---|
| Operating margin | 16.8% | 13.5% | 13.6% | 17.2% | 15.1% |
|---|
| Interest cost | ₹1.65 cr | ₹1.49 cr | ₹1.46 cr | ₹1.56 cr | ₹1.49 cr |
|---|
| Profit before tax | ₹74.82 cr | ₹55.01 cr | ₹56.39 cr | ₹68.31 cr | ₹55.27 cr |
|---|
| Tax expense | ₹18.97 cr | ₹13.31 cr | ₹15.39 cr | ₹16.85 cr | ₹14.26 cr |
|---|
| Effective tax rate | 25.4% | 24.2% | 27.3% | 24.7% | 25.8% |
|---|
| Net profit (PAT) | ₹55.85 cr | ₹41.7 cr | ₹41 cr | ₹51.46 cr | ₹41.01 cr |
|---|
| Net profit margin | 13.8% | 11.4% | 11.0% | 14.1% | 12.3% |
|---|
| Basic EPS | ₹6.09 | ₹4.55 | ₹4.47 | ₹5.61 | ₹4.47 |
|---|
| Diluted EPS | ₹6.09 | ₹4.55 | ₹4.47 | ₹5.61 | ₹4.47 |
|---|
INDRAMEDCO results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +11.3% | +9.3% | — | — | — |
|---|
| Revenue QoQ | +11.3% | -1.8% | +1.8% | +9.4% | — |
|---|
| Operating profit YoY | +8.1% | -2.5% | — | — | — |
|---|
| Operating profit QoQ | +38.4% | -3.0% | -19.5% | +24.9% | — |
|---|
| Net profit YoY | +8.5% | +1.7% | — | — | — |
|---|
| Net profit QoQ | +33.9% | +1.7% | -20.3% | +25.5% | — |
|---|
| EPS YoY | +8.6% | +1.8% | — | — | — |
|---|
| EPS QoQ | +33.8% | +1.8% | -20.3% | +25.5% | — |
|---|
INDRAMEDCO annual results history
Full-year performance for INDRAPRASTHA MEDICAL CORP, useful for reading each quarter in context.
INDRAPRASTHA MEDICAL CORP annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,425 cr | ₹1,307 cr | ₹1,204 cr | ₹1,065 cr |
|---|
| Total expenses | ₹1,191 cr | ₹1,097 cr | ₹1,040 cr | ₹953 cr |
|---|
| Gross profit | ₹501 cr | ₹454 cr | ₹423 cr | ₹345 cr |
|---|
| Operating profit (EBIT) | ₹234 cr | ₹210 cr | ₹164 cr | ₹112 cr |
|---|
| Operating margin | 16.4% | 16.1% | 13.6% | 10.5% |
|---|
| Interest cost | ₹2.93 cr | ₹3.03 cr | ₹1.06 cr | ₹0.46 cr |
|---|
| Profit before tax | ₹246 cr | ₹216 cr | ₹166 cr | ₹117 cr |
|---|
| Tax expense | ₹62.4 cr | ₹55.33 cr | ₹42.15 cr | ₹31.03 cr |
|---|
| Effective tax rate | 25.4% | 25.6% | 25.4% | 26.5% |
|---|
| Net profit (PAT) | ₹184 cr | ₹161 cr | ₹124 cr | ₹86.15 cr |
|---|
| Net profit margin | 12.9% | 12.3% | 10.3% | 8.1% |
|---|
| Basic EPS | ₹20.03 | ₹17.56 | ₹13.52 | ₹9.40 |
|---|
| Diluted EPS | ₹20.03 | ₹17.56 | ₹13.52 | ₹9.40 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹406 cr against ₹365 cr in Q1 FY26, and ₹365 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +11.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹338 cr, or 83.2% of revenue, with operating profit grew +8.1% year on year.
Margins, tax and profitability
Net profit of ₹55.85 cr works out to a net margin of 13.8% compared with 14.1% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, INDRAPRASTHA MEDICAL CORP reported profit before tax of ₹74.82 cr, a tax charge of ₹18.97 cr (effective rate 25.4%), interest cost of ₹1.65 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹41.7 cr in Q4 FY26 to ₹55.85 cr in Q1 FY27, a change of +33.9%.
Trailing twelve months and annual context
Across the trailing four quarters INDRAPRASTHA MEDICAL CORP has generated revenue of ₹1,508 cr and net profit of ₹190 cr, a trailing net margin of 12.6%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,425 cr with net profit of ₹184 cr and EPS of ₹20.03, versus the prior year where revenue grew +9.0% and profit grew +14.1%.
What to watch in the next INDRAMEDCO quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
INDRAPRASTHA MEDICAL CORP has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
INDRAMEDCO results coverage
No results report published for INDRAMEDCO yet — our desk covers each quarter within minutes of the filing.
INDRAMEDCO quarterly results FAQs
What were INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), INDRAPRASTHA MEDICAL CORP reported revenue of ₹406 cr and net profit of ₹55.85 cr, a change of +8.5% year on year on +11.3% revenue growth. EPS stood at ₹6.09.
What is INDRAMEDCO profit margin in Q1 FY27?
INDRAPRASTHA MEDICAL CORP posted a net profit margin of 13.8% and an operating margin of 16.8% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹1,508 cr and net profit ₹190 cr.
Did INDRAMEDCO results beat the previous quarter?
INDRAPRASTHA MEDICAL CORP net profit changed +33.9% quarter on quarter, from ₹41.7 cr in Q4 FY26 to ₹55.85 cr in Q1 FY27.
When are INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) quarterly results?
INDRAPRASTHA MEDICAL CORP has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see INDRAMEDCO latest quarterly results?
Results coverage for INDRAMEDCO will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the INDRAMEDCO stock page.
What is INDRAPRASTHA MEDICAL CORP annual revenue and profit?
For FY26, INDRAPRASTHA MEDICAL CORP reported full-year revenue of ₹1,425 cr and net profit of ₹184 cr, with EPS of ₹20.03.
How many quarterly results has INDRAMEDCO declared recently?
Past results dates for INDRAMEDCO will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
